alanine weakens target binding 11 , the affinities of these variants for on-target and PAM-distal 46 mismatched substrates were similar to WT SpCas9 (Figure 1b, Extended Data Figure 1a, 2b) , 47
The RNA-guided CRISPR-Cas9 nuclease from Streptococcus pyogenes (SpCas9) has been 23 widely repurposed for genome editing 1-4 . High-fidelity (SpCas9-HF1) and enhanced 24 specificity (eSpCas9(1.1)) variants exhibit substantially reduced off-target cleavage in 25 human cells, but the mechanism of target discrimination and the potential to further 26 improve fidelity were unknown 5-9 . Using single-molecule Förster resonance energy transfer 27 (smFRET) experiments, we show that both SpCas9-HF1 and eSpCas9(1.1) are trapped in 28 an inactive state 10 when bound to mismatched targets. We find that a non-catalytic domain 29 within Cas9, REC3, recognizes target mismatches and governs the HNH nuclease to 30 regulate overall catalytic competence. Exploiting this observation, we identified residues 31 within REC3 involved in mismatch sensing and designed a new hyper-accurate Cas9 32 variant (HypaCas9) that retains robust on-target activity in human cells. These results 33 offer a more comprehensive model to rationalize and modify the balance between target 34 recognition and nuclease activation for precision genome editing. 35
36
Efforts to minimize off-target cleavage by CRISPR-Cas9 have motivated the development of 37 SpCas9-HF1 and eSpCas9(1.1) variants that contain amino acid substitutions predicted to 38 weaken the energetics of target site recognition and cleavage 8, 9 (Figure 1a ). Biochemically, we 39 found that these Cas9 variants cleaved the on-target DNA with rates similar to that of wild-type 40 (WT) SpCas9, whereas their cleavage activity was significantly reduced on substrates bearing 41 mismatches (Extended Data Figure 1a, 2a) . To test the hypothesis that SpCas9 with its single-42 guide RNA (sgRNA) might exhibit a greater affinity for its target than is required for effective 43 recognition 9,11 , we measured DNA binding affinity and cleavage of SpCas9-HF1 and 44 eSpCas9(1.1) variants. Contrary to a potential hypothesis that mutating these charged residues to 45 indicating that cleavage specificity is improved through a mechanism distinct from a simple 48 reduction of target binding affinity 11 . 49
The HNH nuclease domain of SpCas9 undergoes a substantial conformational 50 rearrangement upon target binding [12] [13] [14] [15] , which activates the RuvC nuclease for concerted 51 cleavage of both strands of the DNA 12,16 . We have previously shown that the HNH domain 52 stably docks in its active state with an on-target substrate but becomes loosely trapped in an 53 catalytically-inactive conformational checkpoint when bound to mismatched targets 10 , 54
suggesting that SpCas9-HF1 and eSpCas9(1.1) variants may employ a more stringent checkpoint 55 to promote off-target discrimination. To test this possibility, we labeled catalytically active WT 56
SpCas9 (SpCas9 HNH ), SpCas9-HF1 (SpCas9-HF1 HNH ) and eSpCas9(1.1) (eSpCas9(1.1) HNH ) with 57 We therefore propose that high fidelity variants of Cas9 reduce off-target 67 cleavage by raising the threshold for HNH conformational activation when bound to DNA 68
substrates. 69
Since the HNH domain does not directly contact nucleic acids at the PAM-distal end 13,17-70 19 , it is likely that a separate domain of Cas9 senses mismatches to govern HNH domain 71 mobility. Structural studies suggest that a domain within the Cas9 recognition (REC) lobe 72 (REC3) interacts with the RNA/DNA heteroduplex and undergoes conformational changes upon 73 target binding (Extended Data Figure 3 ) 13, 14, [17] [18] [19] . Because the function of this non-catalytic 74 domain was previously unknown, we labeled SpCas9 with Cy3/Cy5 dyes at positions S701C and 75 S960C (SpCas9 REC3 ) and observed that the conformational states of REC3 become more 76 heterogeneous as PAM-distal mismatches increase (Extended Data Figure 4a Figure 4f ). We therefore propose that 86 REC3 acts as an allosteric effector that recognizes RNA/DNA heteroduplex to allow for HNH 87 nuclease activation. 88
We next considered allosteric interactions that could couple the discontinuous REC3 and 89 HNH domains. Structural studies suggested that REC2 occludes the HNH domain from the 90 5 scissile phosphate in the sgRNA-bound state 19 , and undergoes a large outward rotation upon 91 binding to double-stranded DNA (dsDNA) 13, 14 (Figure 2e ). To test whether the REC2 domain 92 regulates access of HNH to the target strand scissile phosphate, we labeled SpCas9 with 93 Next, we investigated if this conformational proofreading mechanism could be rationally 106 exploited to design a suite of novel hyper-accurate Cas9 variants. We identified five clusters of 107 residues containing conserved amino acids within 5 Å of the RNA/DNA interface, four of which 108 are located within REC3 and one in the HNH-RuvC Linker 2 (L2) (Figure 3a , Extended Data 109 Figure 5 ). Alone or in combination with Q926A, a substitution within L2 that confers 110 specificity 9 , we generated alanine substitutions for each residue within five different clusters of 111 amino acids (Clusters 1-5 ± Q926A) ( Figure 3a) . We tested whether these cluster mutations 112 affected off-target discrimination and equilibrium binding in vitro, and found that Cluster 1 alone 113 6 and Cluster 2 + Q926A exhibited the greatest suppression of off-target cleavage while retaining 114 target binding affinities comparable to WT (Extended Data Figure 6 ). We next screened all 115 cluster variants in human cells using an enhanced GFP (EGFP) disruption assay 5 . On-target 116 activity for Cluster 1 was comparable to that of SpCas9-HF1 or eSpCas9(1.1), whereas Cluster 2 117 variants displayed generally lower activity (Figure 3b, Extended Data Figure 7a ). Furthermore, 118
Cluster 1 retained high on-target activity (> 70% of WT) at 19/24 endogenous gene sites tested, 119 compared to 18/24 for SpCas9-HF1 and 23/24 for eSpCas9(1.1) (Figure 3c , Extended Data 120
Figure 8a). 121
We then focused on the specific contributions of mutations within Cluster 1 by restoring 122 each individual mutated residue to its wild-type identity, along with the Q926A mutation, and 123 testing the resulting variants for on-target editing efficiency in human cells. On-target activity 124 was significantly compromised when N692A/Q695A/Q926A mutations occurred together, but 125 restoring either N692 (Cluster 1 N692 + Q926A) or Q695 (Cluster 1 Q695 + Q926A) alone led 126 to robust on-target efficiency comparable to Cluster 1, signifying differential contributions from 127 these mutations to activity and specificity (Extended Data Figure 7b -c, 8a-b). Using sgRNAs 128 with single mismatches against the endogenous human gene target FANCF site 1, we found that 129
Cluster 1 exhibited even greater specificity than both SpCas9-HF1 and eSpCas9(1.1) in the 130 middle and PAM proximal regions of the spacer, suggesting that mutating N692A and Q695A 131 together may induce specificity in parts of the spacer sequence that were previously susceptible 132 to off-target cleavage by high-fidelity Cas9 variants 9 (Figure 3d To biochemically validate cleavage specificity in the middle region of the spacer with 138
HypaCas9, we measured cleavage rates against the FANCF site 1 sequence with or without 139 internal mismatches at positions 10-12 of the spacer. Although HypaCas9 retained on-target 140 activity comparable to WT and SpCas9-HF1 in human cells, its in vitro cleavage rate was 141 slightly reduced for the one target site examined (Figure 4a ). However, the cleavage rate with 142 internally mismatched substrates was considerably slower compared to WT and SpCas9-HF1 143 Our findings provide direct evidence to support previous speculation that Cas9 relies on 150 PAM-distal protospacer sensing to enable accurate targeting 21, 22 . In particular, we define REC3 151
as an allosteric regulator of global Cas9 conformational changes to activate the nuclease 152 domains, whose conformational threshold can be tuned for high-fidelity cleavage. Mutation of 153 residues within REC3 that are involved in nucleic acid recognition, such as those mutated in 154
HypaCas9 or SpCas9-HF1, prevents transitions by the REC lobe, which more stringently traps 155 the HNH domain in the conformational checkpoint in the presence of mismatches (Figure 4c , 156 Extended Data Figure 9) . Curiously, nearly all of the amino acids within the cluster variants 157
were strongly conserved (Extended Data Figure 5 ), suggesting that these residues may also be 158 8 involved in protospacer sensing and HNH nuclease activation across Cas9 orthologues. 159
Furthermore, this observation may address how nature apparently has not selected for a highly 160 precise Cas9 protein, whose native balance between mismatch tolerance and specificity may be 161 optimized for host immunity. Our study therefore delineates a general strategy for improving 162
Cas9 specificity by tuning conformational activation and offers innovative opportunities for 163 rational design of hyper-accurate Cas9 variants that do not compromise efficiency. were pre-incubated with 10-fold molar excess of REC3 for at least 10 minutes at room 209 temperature before addition of radiolabeled substrate. DNA cleavage experiments were 210 performed and analyzed as previously described 12 . DNA binding assays were conducted in 1X 211 binding buffer without MgCl 2 + 1 mM EDTA at room temperature for 2 hours. DNA-bound 212 complexes were resolved on 8% native PAGE (0.5X TBE + 1 mM EDTA, without MgCl 2 ) at 213 4°C, as previously described 10 . Experiments were replicated at least three times, and presented 214 gels are representative results. for human cell culture are available in Supplementary Table 1 and 2. Nuclease variants were 261 generated by isothermal assembly into JDS246 (Addgene #43861) 5 , and guide RNAs were 262 cloned into BsmBI digested BPK1520 (Addgene #65777) 25 . Both U2OS cells (a gift from Toni 263 Cathomen, Freiburg) and U2OS-EGFP cells (encoding a single integrated copy of a pCMV-264 EGFP-PEST cassette) 26 were cultured at 37 °C with 5% CO 2 in advanced DMEM containing 265 10% heat-inactivated fetal bovine serum, 2 mM GlutaMax, penicillin/streptomycin, and 400 µg 266 ml -1 Geneticin (for U2OS-EGFP cells only). Cell culture reagents were purchased from Thermo 267 Coulter Genomics), and T7 endonuclease I assays were performed as previously described 26 . 281
Briefly, 600-800 nt amplicons surrounding on-target sites were amplified from ~100 ng of 282 genomic DNA using Phusion Hot-Start Flex DNA Polymerase (New England Biolabs) using the 283 primers listed in Supplementary Table 2 . PCR products were visualized (using a QIAxcel 284 capillary electrophoresis instrument, Qiagen), and purified (Agencourt Ampure XP cleanup, 285
Beckman Coulter Genomics), Denaturation and annealing of ~200 ng of the PCR product was 286 followed by digestion with T7 endonuclease I (New England Biolabs). Digestion products were 287 purified (Ampure) and quantified (QIAxcel) to approximate the mutagenesis frequencies induced 288 by Cas9-sgRNA complexes. 
